Related Experiment Video
Updated: May 19, 2026

Primary Culture of Mouse Dopaminergic Neurons
Published on: September 8, 2014
Normal midbrain dopaminergic neuron development and function in miR-133b mutant mice
Mary P Heyer1, Amar K Pani, Richard J Smeyne
1Department of Neurobiology, Duke University Medical Center, Durham, North Carolina 27710, USA.
Abstract:
Midbrain dopaminergic (mDA) neurons control movement and emotion, and their degeneration leads to motor and cognitive defects in Parkinson's disease (PD). miR-133b is a conserved microRNA that is thought to regulate mDA neuron differentiation by targeting Pitx3, a transcription factor required for appropriate development of mDA substantia nigra neurons. Moreover, miR-133b has been found to be depleted in the midbrain of PD patients. However, the function of miR-133b in the intact midbrain has not been determined. Here we show that miR-133b null mice have normal numbers of mDA neurons during development and aging. Dopamine levels are unchanged in the striatum, while expression of dopaminergic genes, including Pitx3, is also unaffected. Finally, motor coordination and both spontaneous and psychostimulant-induced locomotion are unaltered in miR-133b null mice, suggesting that miR-133b does not play a significant role in mDA neuron development and maintenance in vivo.
Insights
MicroRNA-133b (miR-133b) does not appear to be essential for midbrain dopaminergic neuron development or function in mice. Studies found no significant impact on neuron numbers, dopamine levels, or motor behaviors in miR-133b deficient mice.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Midbrain dopaminergic (mDA) neurons are crucial for motor control and emotion, with their degeneration linked to Parkinson's disease (PD).
- MicroRNA-133b (miR-133b) has been implicated in mDA neuron differentiation, potentially by regulating the transcription factor Pitx3.
- Reduced miR-133b levels are observed in the midbrain of PD patients, suggesting a potential role in the disease.
Purpose of the Study:
- To investigate the in vivo function of miR-133b in the development and maintenance of midbrain dopaminergic neurons.
- To determine if miR-133b plays a role in motor control and locomotion.
Main Methods:
- Generation and analysis of miR-133b null mice.
- Assessment of mDA neuron numbers during development and aging.
- Measurement of striatal dopamine levels and expression of dopaminergic genes (including Pitx3).
- Evaluation of motor coordination and locomotion behaviors.
Main Results:
- miR-133b null mice exhibited normal numbers of mDA neurons throughout development and aging.
- Dopamine levels in the striatum and expression of dopaminergic genes, such as Pitx3, remained unaffected.
- Motor coordination and spontaneous/psychostimulant-induced locomotion were unaltered in the absence of miR-133b.
Conclusions:
- miR-133b does not appear to play a significant role in the development or maintenance of midbrain dopaminergic neurons in vivo.
- The findings suggest that miR-133b's previously proposed regulatory function in mDA neuron differentiation may not be critical under normal physiological conditions.
- This study challenges the presumed importance of miR-133b in mDA neuron biology and Parkinson's disease pathogenesis.
